IP Library Granted Patent US 8,660,654
Granted Patent B2
US 8,660,654 · App. 13/725,770 · Granted Feb 25, 2014

Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,660,654
App. No.
13/725,770
Granted
Feb 25, 2014
Kind
B2
Abstract

Selective high-frequency spinal cord modulation for inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal cord region to address low back pain without creating unwanted sensory and/or motor side effects. In other embodiments, modulation in accordance with similar parameters can be applied to other spinal or peripheral locations to address other indications.

Claims (54)

1. A method for configuring a signal generator to deliver a therapy signal to a patient's spinal cord region the method comprising:

programming or instructing the programming of the signal generator to

(1) generate a non-paresthesia-producing therapy signal, wherein at least a portion of the therapy signal has a frequency in a frequency range of from about 1.5 kHz to about 100 kHz; and

(2) deliver the therapy signal to the patient's spinal cord region via an implantable signal delivery device.

2. The of claim 1 , further comprising:

identifying or instructing identification of the frequency as one that at least partially reduces the patient's sensation of pain without generating paresthesia.

3. The method of claim 2 , wherein the frequency is between about 3 kHz and about 20 kHz.

4. The method of claim 2 , wherein identifying or instructing identification is performed prior to programming or instructing programming.

5. The method of claim 1 , further comprising implanting instructing or instructing implantation of the implantable signal deliver device proximate to a vertebral level between about T9 and about T12, and wherein the therapy signal at least partially reduces the patient's sensation of pain in the lower back or leg.

6. The method of claim 1 , further comprising implanting instructing or instructing implantation of the implantable signal deliver device proximate to a thoracic vertebral level, and wherein and the therapy signal at least partially reduces the patient's sensation of pain associated with shingles.

7. The method of claim 1 , further comprising implanting or instructing implantation of the implantable signal deliver device proximate to a vertebral level between about C 3 and about C 7 , and wherein the therapy signal at least partially reduces the patient's sensation of pain associated with chronic regional pain syndrome.

8. A method for configuring a signal generator to deliver a therapy signal to a patient's spinal cord region, wherein the signal generator is electrically coupleable to at least one implantable signal delivery device, and wherein the implantable signal delivery device is implantable proximate to the patient's spinal cord region, the method comprising:

programming or instructing the programming of the signal generator to

(1) generate a therapy signal, wherein at least a portion of the therapy signal is at a suprathreshold current amplitude in an amplitude range of from about 0.5 mA to about 6 mA and a frequency of about 10 kHz; and

(2) deliver the therapy signal to the patient's spinal cord region, via the at least one implantable signal delivery device, wherein the signal does not induce paresthesia in the patient.

9. The method of claim 8 , wherein the therapy signal at least partially reduce the patient's sensation of pain without affecting neural transmissions of touch or heat.

10. The method of claim 8 , further comprising:

programming or instructing the programming of the signal generator to generate the therapy signal with at least a portion of the therapy signal being a bi-phasic square-wave.

11. The method of claim 10 , further comprising:

programming or instructing the programming of the signal generator to apply the therapy signal at a duty cycle.

12. The method of claim 10 , wherein at least a portion of the therapy signal has a pulse width between about 25 microseconds and about 166 microseconds.

13. The method of claim 12 , further comprising:

programming or instructing the programming of the signal generator to apply the therapy signal at a duty cycle.

14. A method for configuring a signal generator to deliver a therapy signal to a patient's spinal cord region, wherein the signal generator is electrically coupleable to at least one implantable signal delivery device, and wherein the implantable signal delivery device is implantable proximate to the patient's spinal cord region, the method comprising:

programming or instructing the programming of the signal generator to generate and deliver a therapy signal to the patient's spinal cord region, via the at least one implantable signal delivery device, wherein at least a portion of the therapy signal has

a frequency in a frequency range of from about 1.5 kHz to about 50 kHz,

a current amplitude in an amplitude range of from about 0.1 mA to about 6 mA,

a pulse width between about 10 microseconds and about 333 microseconds, and

at least partially reduces the patient's sensation of pain without generating paresthesia.

15. The method of claim 14 , wherein the frequency is set to about 10 kHz and the pulse width is between about 30 microseconds and about 35 microseconds.

16. The method of claim 15 , further comprising:

programming or instructing the programming of the signal generator to apply the therapy signal at a duty cycle.

17. The method of claim 14 , further comprising implanting or instructing implantation of the signal deliver device proximate to a vertebral level between about T9 and about T10, and wherein the therapy signal at least partially reduces the patient's sensation of pain in the lower back or leg.

18. The method of claim 14 , further comprising implanting or instructing implantation of the signal deliver device is proximate to a thoracic vertebral level, and wherein the therapy signal at least partially reduces the patient's sensation of pain associated with shingles.

19. The method of claim 14 , further comprising implanting or instructing implantation of the signal deliver device proximate to a vertebral level between about C 3 and about C 7 , and wherein the therapy signal at least partially reduces the patient's sensation of pain associated with chronic regional pain syndrome.

20. The method of claim 14 , further comprising:

programming or instructing the programming of the signal generator to apply the therapy signal at a duty cycle.

21. The method of claim 14 , wherein the frequency range is from about 3 kHz to about 20 kHz and the pulse width is between about 25 microseconds and about 166 microseconds.

22. The method of claim 14 , wherein the frequency range is from about 5 kHz to about 15 kHz.

23. A method for configuring a signal generator to deliver a therapy signal to a patient's spinal cord region, wherein the signal generator is electrically coupleable to at least one implantable signal delivery device, and wherein the implantable signal delivery device is implantable proximate to a vertebral level between about T9 and about T12 in the patient's spinal cord region, the method comprising:

(1) identifying or instructing identification of a frequency for a therapy signal as one that at least partially reduces the patient's sensation of pain without generating paresthesia, wherein the frequency is in a frequency range of from about 3 kHz to about 20 kHz; and

(2) programming or instructing the programming of the signal generator to

(a) generate the therapy signal, wherein at least a portion of the therapy signal is at the identified frequency, and wherein at least a portion of the therapy signal is

a bi-phasic square-wave with

a current amplitude in an amplitude range of from about 0.5 mA to about 4 mA, and

a pulse width between about 25 microseconds and about 166 microseconds; and

(b) deliver the therapy signal via the at least one implantable signal delivery device.

24. The method of claim 23 , wherein the therapy signal at least partially reduces the patient's sensation of pain without affecting neural transmissions of touch or heat.

25. The method of claim 24 , further comprising implanting or instructing implantation of the signal deliver device is proximate to the vertebral level between about T9 and about T10.

26. The method of claim 25 , wherein the identified frequency is about 10 kHz.

27. The method of claim 26 , further comprising:

programming or instructing the programming of the signal generator to apply the therapy signal at a duty cycle.

28. The method of claim 23 , wherein at least a portion of the therapy signal has a pulse width between about 30 microseconds and about 35 microseconds.

29. The method of claim 23 , wherein the identified frequency is between about 5 kHz and about 15 kHz.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: NEVRO CORP.
Reel/Frame 070743/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2023
From: NEVRO CORP.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 065744/0302 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME PREVIOUSLY RECORDED AT REEL: 030647 FRAME: 0229. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 21, 2016
From: ALATARIS, KONSTANTINOS; WALKER, ANDRE B.; PARKER, JON; CHITRE, YOUGANDH; PARK, SANGSOO WESLEY; THACKER, JAMES R.
To: NEVRO CORP.
Reel/Frame 040658/0075 →
RELEASE OF SECURITY INTEREST Recorded Jun 27, 2016
From: CRG SERVICING LLC
To: NEVRO CORP.
Reel/Frame 039168/0890 →
ASSIGNMENT AGREEMENT (REAFFIRMATION) Recorded Jun 13, 2016
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: CRG SERVICING LLC,
Reel/Frame 038984/0865 →
SECURITY INTEREST Recorded Dec 12, 2014
From: NEVRO CORP.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 034619/0546 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 19, 2013
From: ALATARIS, KONSTANTINOS; WALKER, ANDRE B.; PARKER, JON; CHITRE, YOUGANDH; PARK, SANGSOO WESLEY; THACKER, JAMES R.
To: NEVRO CORPORATION
Reel/Frame 030647/0229 →